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Abstract
Multiple loss-of-function (LOF) alleles at the same gene may influence a phenotype not only in the homozygote state when
alleles are considered individually, but also in the compound heterozygote (CH) state. Such LOF alleles typically have low
frequencies and moderate to large effects. Detecting such variants is of interest to the genetics community, and relevant
statistical methods for detecting and quantifying their effects are sorely needed. We present a collapsed double
heterozygosity (CDH) test to detect the presence of multiple LOF alleles at a gene. When causal SNPs are available, which
may be the case in next generation genome sequencing studies, this CDH test has overwhelmingly higher power than
single SNP analysis. When causal SNPs are not directly available such as in current GWA settings, we show the CDH test has
higher power than standard single SNP analysis if tagging SNPs are in linkage disequilibrium with the underlying causal
SNPs to at least a moderate degree (r
2.0.1). The test is implemented for genome-wide analysis in the publically available
software package GenABEL which is based on a sliding window approach. We provide the proof of principle by conducting
a genome-wide CDH analysis of red hair color, a trait known to be influenced by multiple loss-of-function alleles, in a total of
7,732 Dutch individuals with hair color ascertained. The association signals at the MC1R gene locus from CDH were
uniformly more significant than traditional GWA analyses (the most significant P for CDH=3.11610
2142 vs. P for
rs258322=1.33610
266). The CDH test will contribute towards finding rare LOF variants in GWAS and sequencing studies.
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Introduction
Genome-wide association studies (GWAS) have successfully
identified thousands of common variants associated with many
complex human phenotypes including common diseases (www.
genome.gov/gwastudies). However, with a few exceptions, com-
mon variants identified to date explain only a small fraction of the
overall heritability of the traits studied. It was speculated that
searching for common variants with increasingly smaller effects
are unlikely to substantially account for the missing heritability [1].
Thus, there have been calls for shifting the attention from genome
scans of larger samples to studies of rarer variants with larger effect
[2]. In particular, it has been proposed that heterozygous loss-of-
function (LOF) variants may account for an essential portion of the
missing heritability [1,3].
LOF variants represent alleles resulting in reduced or abolished
protein function by disrupting not only the protein-coding genes
but also any essential genetic element, including non-coding
regulatory motifs. They have a variety of forms, including single-
base substitutions such as nonsense SNPs or splice site disruptions
and small or larger insertions/deletions that change the reading
frame or remove an entire gene. These are surprisingly common in
healthy individuals in that gene disruption, as a result of positive
selection, can be beneficial [4,5]. On the other hand, people at the
extremes of trait distributions are more likely to carry trait-
associated LOF variants [6]. LOF variants are mostly recognized
by their genetic association with a variety of phenotypes largely
inherited in a recessive manner. It is important to note multiple
LOF variants at the same locus can act not only in the homozygote
state, but also in the compound heterozygote (CH) state, where the
presence of two different LOF variant alleles at the same gene, one
on each homologue chromosome, influence the phenotype. In
such cases, the CH state would be much more frequent than the
homozygote state for any individual variant. We thus expect a
power gain by taking the CH state into account in GWAS or in
genome sequencing studies.
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28145There are numerous convincing examples that multiple LOF
variants in a gene collectively influence a phenotype. Some
examples are HFE and hemochromatosis [7], PLA2G7 and
coronary heart diseases [8], SLC22A12/SLC2A9 and renal
hypouricemia [9,10], KCNQ1 and Jervell and Lange-Nielsen
syndrome [11], NCCT and Gitelman ´s syndrome [12], ABCC6/
GGCX and pseudoxanthoma elasticum [13,14,15], TG and
congenital goiter [16], SCN5A and Brugada syndrome [17],
P2RX7 and inflammatory response [18], ABCA12 and congenital
ichthyoses [19], TRIM32 and nephrogenic diabetes insipidus [20],
WFS1 and Wolfram syndrome [21], and CLDN16 and hypo-
magnesaemia [22]. Through this study we use LOF variants in
MC1R and red hair color as an example where empirical data
were available. Polymorphisms leading to complete loss of function
of MC1R are responsible for the red hair/fair skin pigmentation
phenotype [23], characterized by tendency to burn and inability to
tan, and has been significantly linked to the development of UV-
induced skin cancer, in particular melanoma. At least 9 distinct
variants in MC1R contribute to an increased chance of developing
red hair [23,24,25,26]. The relative chance for the red hair
phenotype was estimated to be, in general, 15-fold greater among
the individuals carrying any single variant allele, compared to non-
carriers, and 170-fold higher among homozygotes or CH carriers
[23]. A GWAS in 2,986 Icelanders based on the Illumina 317K
chip successfully confirmed the association between red hair and
variants in MC1R where the most significant signal was derived
from a tagging SNP (rs4785763 P=3.2610
256) [26]. The authors
subsequently achieved a much stronger association by additionally
genotyping two nonsynonymous SNPs not assayed on this chip
(rs1805007 P=2.0610
2142, rs1805008 P=4.2610
295). The fact
that the causal alleles have an extraordinarily large effect which is
sufficiently frequent in European populations (0.142 for rs1805007
and 0.108 for rs1805008 in HapMap CEU) allowed successful
detection of the genome-wide significant signals from these tagging
SNPs. However, in more common situations such LOF variants
may have smaller effect sizes and can occur at lower frequencies,
and so be undetectable, even if they are directly observed through
the next generation sequencing techniques. Relevant statistical
methods for detecting and quantifying their effects are sorely
needed.
It was speculated that an increased statistical power may be
achieved by analyzing multiple neighboring low-frequency
variants simultaneously. Several methods have been proposed
for analyzing a collection of selected rare mutations to test for
group-wise association with a disease status. Recent developments
in this area include the cohort allelic sums test (CAST) [27], the
combined multivariate and collapsing (CMC) method [28], and
the weighted sum statistic (WSS) [29]. In the CAST method, the
overall frequency of all exonic alleles in a gene is compared
between cases and controls. In the CMC method, all selected rare
variants are collapsed and treated as a single common variant
allele. The WSS method jointly analyzes a group of rare mutations
to test for an excess of mutations in cases. Madsen et al. [29]
compared the performance of CAST, CMC, and WSS and
showed that WSS was the most powerful under four genetic
models. In general, the power of these methods depends on the
portion and the frequency of causal variants included. However,
none of these methods focused on the CH and they are most
suitable for analyzing exonic regions with a collection of rare and
possibly functional alleles.
Here, we aim to develop a computationally efficient method to
screen for multiple LOF variants, which does not rely on function
annotation. The performance of this method is evaluated based on
simulated phenotypes and real genotypes from the Illumina 550K
chip available for 10,213 Dutch individuals from the Rotterdam
Study, and compared with single SNP analysis and WSS. Finally,
we provide a proof of principle using a GWAS of red hair in 7,732
participants who provided information on their hair color.
Materials and Methods
Rotterdam Study, microarray genotypes, and hair color data
The Rotterdam Study (RS1) [30] has been in operation since
1990 and initially included 7,983 participants living in Rotterdam,
The Netherlands. The RS2 [31] is an extension of the cohort,
started in 1999 and includes 3,011 participants. The RS3 [32] is a
further extension of the cohort started in 2006 and includes 3,932
participants. RS1 and RS2 were genotyped using the Infinium II
HumanHap550 K Genotyping BeadChip version 3.and RS3 was
genotyped using Human 610 Quad Arrays of Illumina. Collection
and purification of DNA, genotyping, imputation, merging, and
quality control details have been described before [33,34]. Hair
color was collected in RS1 and RS2 by means of a questionnaire,
with self reporting of 4 hair color categories; fair, brown, red, or
black when young. After quality control, this study included a total
of 10,213 individuals with 550 K genotyped SNPs, among whom
7,732 individuals provided hair color information (N red
hair=241). The Medical Ethics Committee of Erasmus Medical
Center, Rotterdam, approved this study. All participants provided
written informed consent.
MC1R SNP genotyping
Multiple LOF mutations in MC1R cause red hair color. These
mutations are largely recessive when considered individually and
interact with each other in compound heterozygotes. Two SNPs
rs1805007 (R151C) and rs1805008 (R160W) known to have the
largest effects [24] but not present on the Illumina 550 K chip,
were genotyped separately using melt curve genotyping. The assay
design and primer synthesis were done by Tib Molbiol (Berlin,
Germany, Table S1). For laboratory details see Text S1.
Expected P values from the CDH test of 2 causal SNPs
The expected P values from the CDH test of 2 causal SNPs was
mathematically derived as described below (also illustrated using
an excel macro Table S2). Consider two physically close SNPs
with low MAFs (1–5%). When their LD is low (as measured by r
2),
they approximately and independently follow HWE. The fre-
quency of the combined genotypes is expected to follow:
R~
(1{q1)
2(1{q2)
2 2(1{q1)
2(1{q2)q2 (1{q1)
2q2
2
2(1{q1)q1(1{q2)
2 4(1{q1)q1(1{q2)q2 2(1{q1)q1q2
2
q2
1(1{q2)
2 2q2
1(1{q2)q2 q2
1q2
2
8
> <
> :
9
> =
> ;
,
where q1 and q2 are the frequencies of minor alleles. Note here
because q1 and q2 are small, R(2,3), R(3,2), and R(3,3) are close to
zero. The CH state R(2,2) is more frequent than the homozygote
state of either SNP (R(1,3) and R(3,1)), for example, when q1=q2,
R(2,2)
 
R(1,3)~R(2,2)
 
R(3,1)~4:
Consider a genetic model in which the homozygote and
compound heterozygote genotypes lead to an increased prevalence
of a binary phenotype, so that the joint penetrance table of the two
SNPs can be modeled using a baseline prevalence a, together with
a GRR, denoted as b here.
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Given the total sample size n, the expected genotype count in cases
is the element by element multiplication of R and F
D~nRF,
as well as in controls
U~nR(1{F):
Note here we consider population based studies typically consist
of a large number of healthy individuals and a small number of
cases in terms of rare diseases or extreme phenotypes. This is
different from the conventional case-control designs where subjects
are selected based on the status of a particular disease. Therefore,
n needs to be sufficiently large to reach reasonable power, for
example, one would need 10,000 population samples to obtain
500 cases for a phenotype with 5% prevalence. However, the
definitions of D and U can be easily modified if the number of
cases and controls are fixed by design.
Based on F, a two-by-two contingency table can be formed by
collapsing the lower triangle cells in both cases and controls
O~
P
D{(D(1,1)zD(1,2)zD(2,1))
P
U{(U(1,1)zU(1,2)zU(2,1))
D(1,1)zD(1,2)zD(2,1) U(1,1)zU(1,2)zU(2,1)
  
:
In single SNP analysis, a two-by-three table can be formed,
O~
P 3
i~1
D(1,i)
P 3
i~1
D(2,i)
P 3
i~1
D(3,i)
P 3
i~1
U(1,i)
P 3
i~1
U(2,i)
P 3
i~1
U(3,i)
8
> > > > > > > > <
> > > > > > > > :
9
> > > > > > > > =
> > > > > > > > ;
,
where O is an expected matrix of counts under the alternative
hypothesis (not confused with real observations). The Chi-square
value is computed using standard operations for contingency
tables,
c~
X(O{E)
2
E
,
which follows the Chi-square distribution with 1 df for CDH test
and 2 df for a single SNP test. The expected P values from the
CDH analysis of causal SNPs are compared with those from the
single SNP analysis under comparable parameters, in which we set
q=q1=q2 for illustration purposes.
SNP sampling and trait simulation
Two physically close (,200 kb) SNPs S1 with alleles a and A
(frequency of A 1% to 5%) and S2 with alleles b and B (frequency
of B 1% to 5%) were randomly sampled 10,000 times without
replacement over the Illumina 550 K chip in the Rotterdam Study
(N individuals=10,213). The r
2 values between SNPs a and b are
derived (Figure S1). For each SNP pair, we simulated a set of
binary trait status at the fixed baseline prevalence of 5% under
various GRR ranging from 1 to 10, where GRRAA=GRRBB=GR-
RaAbB. The GRR=1 represents the null hypothesis of no genetic
association. The tagging SNP S3 with alleles c and C is selected if it
is in LD with S1 and the tagging SNP S4 with alleles d and D is
selected if it is in LD with S2 based on various r
2 thresholds
(ranging from 0 to 1) without any constraint on MAF. The SNPs
S1, S2, S3, and S4 were tested for association with the simulated
trait separately using a Chi-squared test with 2 df. The CDH test
was conducted for the collapsed genotypes between SNPs S1 and
S2 and between S3 and S4 using Chi-squared test with 1 df.
Compare CDH and WSS
Madsen et al. [29] have compared the performance of the
CAST, CMC, and WSS methods for testing associations involving
rare variants and showed that WSS was the most powerful under
four genetic models: recessive-set, recessive, additive and domi-
nant. The recessive-set model is the same model as considered in
this study. We compared the power of CDH with WSS under
recessive-set model using simulations and focus on the scenarios
whether or not causal SNPs were directly observed. Under both
scenarios, the proportion of causal SNPs in a genomic region is
variable and other parameters are fixed (GRR=10, N individu-
als=10,000, a=0.05). WSS was implemented as described in [29]
using a permutation correction of k=1000 as suggested. The
CDH test was conducted in a pair-wise manner and the minimal P
value was Bonferroni corrected by the total number of tests
(n(n21)/2). The P-value threshold of 0.05 was used for rejecting
the null hypothesis of no association. A region spanning 200 kb
was randomly sampled 10,000 times over the Illumina 550 K
chip. For each sampling, a binary trait was simulated by con-
sidering a portion of the low frequency variants (MAF,0.05) in
the region to be causal under the recessive-set model. Other para-
meters were fixed (a=0.05, N=10,000, and GRR=10 for carriers
of any homozygote or CH genotype of the causal variants). Four
scenarios were investigated where (1) all SNPs in the region were
analyzed by CDH, (2) all SNPs with MAF,0.05 were analyzed by
WSS, (3) all non-causal SNPs were analyzed by CDH, and (4) all
non-causal variants with MAF,0.05 were analyzed by WSS.
We also compared WSS with CDH using empirical hair color
data. The MC1R region from 87.88 to 88.69 Mb on chromosome
16 encompassed 90 genotyped SNPs with call rate.95% and was
selected for testing association with red hair using CDH and WSS.
The two additionally genotyped causal SNPs rs1805007 and
rs1805008 were included in or excluded from the region, mi-
micking the scenarios where causal variants are directly available
or not. SNPs in this region were cumulatively included into the
WSS analysis according to their MAF in ascending order. All
SNPs in the MC1R region were analyzed by CDH in a pair-wise
manner, and the minimal P value was Bonferroni corrected by the
total number of tests (n=4005).
GWA analysis
The GWA analysis was conducted using GenABEL [35] and
followed closely the methods previously described [34]. The
inflation factor for red hair color was 1.01. Adjusting for gender
and the main principal components from the multidimensional
scaling analysis did not alter GWA results. Age was adjusted at the
stage of phenotype ascertainment (recalled hair color when young).
Single SNP analysis was performed using a score test (qtscore) in
GenABEL with 2df. In order to check if CH, rather than double
heterozyotes, may indeed explain the identified association, we
inferred haplotypes using the expectation maximization algorithm
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were annotated according to the NCBI genome-build version
36.3.
Results
The CH model
We consider a genetic model mimicking the situation where
recessive and CH genotypes of two low-frequent variants are
responsible for the genetic association with a binary phenotype
(Figure 1). Consider two SNPs with common alleles a and b and
minor alleles A and B, which are causal and of low frequency
(1%,MAF,5%). Each SNP is largely recessive when considered
individually, meaning homozygotes for any of the causal alleles (AA
or BB) leads to an increased genotypic relative risk (GRR)o f
expressed phenotype (Figure 1). When two SNPs are considered
jointly, not only the homozygote genotypes but also the CH
genotype (AaBb) leads to an increased GRR. Here the causal alleles
A and B are assumed to reside on different haplotypes as suggested
previously [3,4,10,11], meaning frequencies of the AABb, AaBB,
and AABB genotypes are close to zero. We examined this
assumption empirically using the r
2 value, because a low r
2 value
would indicate A and B resided on different haplotypes. Note D’,
another frequently used LD measurement, is not necessarily low
or high when A and B alleles reside on different haplotypes. A
pair of two physically close (,200 kb) and low-frequent
(1%,MAFs,5%) SNPs was resampled (N resampling=10,000)
over the genome (Illumina 550 K chip) in the Rotterdam Study (N
individuals=10,213). The majority (56.3%) of SNP pairs showed
very low r
2 (,0.01, Figure S1). For the SNP pairs with low r
2, the
Figure 1. A recessive and compound heterozygote model of the phenotype. At left part of the figure (A and B) two rare recessive variants at
the same gene locus are assumed to be directly genotyped. At the right part of the figure (C and D) two non-causal SNPs with higher minor allele
frequencies and in LD with the causal SNPs are genotyped. The upper part of the figure depicts the logarithm scaled frequency of the cross
genotypes of two variants (A and C). The lower part of the figure is an example of the genetic model under illustrative parameters. GRRAA=8,
GRRAaBb=7,GRRBB=6,rac
2=rbd
2=0.1 (B and D).
doi:10.1371/journal.pone.0028145.g001
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(0.25%) were small and the frequencies of AABb, AaBB, and AABB
were close to zero (Figure 1). The frequency of the AaBb genotype
was on average 2.27 times higher than that of the AAbb or aaBB
genotypes. About 18% SNP pairs were in high LD (r
2.0.9,
Figure S1). Because the cross genotypes for two SNPs in high LD
provided little or no additional information than that provided by
either SNP alone (Figure S2), our model focuses on the low r
2
scenario. We developed a simple test, named the collapsed double
heterozygote (CDH) test, to detect the association caused by this
particular genetic model.
CDH test of two causal SNPs
We first considered the scenario where two causal SNPs
are directly genotyped, which is notably unrealistic for SNP
microarray data but may be the case in next generation genome
sequencing studies. The CDH test is based on the Chi-squared test
as defined below. We denote the two causal SNPs as S1 with alleles
a and A and S2 with alleles b and B. Let D and U be observed
genotype counts in cases and controls and both follow a 3-by-3
matrix form,
aabb aAbb AAbb
aabB aAbB AAbB
aaBB aABB AABB
8
> <
> :
9
> =
> ;
The observed matrix of counts is collapsed as,
O~
P
D{(D(1,1)zD(1,2)zD(2,1))
P
U{(U(1,1)zU(1,2)zU(2,1))
D(1,1)zD(1,2)zD(2,1) U(1,1)zU(1,2)zU(2,1)
  
:
Figure 2. The expected P values for the CDH test. The 2log10(P) values for two causal SNPs (on the left part of the figure, A and B) and for the
single SNP chi-squared test (on the right part, C and D) are derived as a function of the genotype relative risk (GRRAA=GRRBB=GRRAaBb ranging from 1
to 10), the minor allele frequencies (q=q1=q2 ranging from 0.01 to 0.05 when N is fixed at 10,000; A and C), and the total sample size N (ranging from
6,000 to 10,000 when q is fixed at 0.05; B and D). The base line prevalence of a binary phenotype is fixed at 5% in all analyses.
doi:10.1371/journal.pone.0028145.g002
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contingency tables,
c~
X(O{E)
2
E
,
which follows the Chi-square distribution with 1 df. Note that there
is an essential difference in the way that the genotypes are
collapsed when tagging SNPs are analyzed (see the section of
tagging SNPs).
The expected P values from the CDH analysis of two causal
SNPs and from the single SNP analysis were mathematically
derived as a function of total sample size N, minor allele
frequencies of causal SNPs q (q1=q2 for simplicity), and GRR
when the base line prevalence of the phenotype a is fixed at 5%.
Under the CH model the CDH analysis would be expected to give
more significant P values than single SNP analyses (Figure 2). For
example, with N=10,000, and 0.02,q,0.05, the CDH analysis is
expected to give genome-wide significant P values (,5610
28) for
detecting reasonably large effect sizes GRR.3. With the same
sample size, it requires higher minor frequencies (q$0.05) and
larger effect sizes (GRR.5.5) for the single SNP analyses to
become genome-wide significant. Note this CDH test gives less
significant P values than single SNP analysis for other genetic
models where AaBb has no effect. For example, consider 2
independent recessive SNPs or single SNP effect (Figure S3). We
then evaluated the type-1 error rate and the statistical power for
CDH using the real genotypes from the Rotterdam Study and
simulated phenotypes (Table 1). The type-1 error rates from
CDH and the single SNP analysis, whether under the additive or
recessive models, were both consistent with the expected under the
null hypothesis of no association (,5% P values smaller than 0.05).
Under the alternative hypothesis (GRR.1), the CDH test showed
much higher power than the single SNP analyses. For example, at
GRR=5, CDH had 52.5% power whereas single SNP analysis
had less than 1% power at the significance threshold of 5610
28
(Table 1). The gain in power using the collapsed genotypes was
overwhelming even when a much more stringent threshold of
5610
211 was applied only for CDH (Table 1). This extra adjust-
ment allows additional multiple testing in real applications, such as
genome-wide implementations based on a sliding window
approach or regional implementations based on a pair-wise testing
approach (see implementation section).
CDH test of two tagging SNPs
A more realistic scenario in GWAS based on SNP microarrays
consisting of mainly common variants is that only non-causal
tagging SNPs were available. For this scenario we considered two
tagging SNPs, S3 with alleles c and C and S4 with alleles d and D.
The tagger S3 was selected if it was in LD with S1, and the tagger
S4 was selected if it was in LD with S2 based on various r
2
thresholds without constraints on MAF. For a given SNP with
MAF ,5% on the Illumina 550 K chip, there was a good chance
(on average 72.74%) of obtaining at least one SNP with an r
2.0.1
from its 100 neighboring SNPs. The chance of obtaining at
least one SNP with r
2.0.5 was much lower (on average 25.26%).
The joint penetrance table for tagging SNPs showed a distinct
interaction pattern differing from those previously considered for
unlinked loci [37]. An important empirical finding was that only
the off-diagonal cells in the cross-genotype table showed any
increased GRR, but the CCDd, CcDD, and CCDD carriers did not
have an increased GRR (Figure 1). This feature, which appeared
to be an antagonistic interaction, can be explained by the very low
frequency of the AB haplotypes (also see the section of the hair
color analysis). This indicates the CDH test is preferred for
analysis of the tagging SNPs but the CCDd, CcDD, and CCDD
genotypes should be collapsed together with wildtypes. Again, let
D and U be observed genotype counts in cases and controls,
ccdd cCdd CCdd
ccdD cCdD CCdD
ccDD cCDD CCDD
8
> <
> :
9
> =
> ;
The observed matrix of counts for tagging SNP analysis is
collapsed as,
O~
D(1,3)zD(2,2)zD(3,1) U(1,3)zU(2,2)zU(3,1)
P
D{(D(1,3)zD(2,2)zD(3,1))
P
U{(U(1,3)zU(2,2)zU(3,1))
  
:
In practice this form can also be used in causal SNP analysis
because AABB, AAbB,a n daABB are negligible. Since it was
difficult to mathematically derive the expected P values for the
CDH test of tagging SNPs, we evaluated type-1 error and power
based on simulations. The type-1 error rate for CDH test was
consistent with the expected under the null hypothesis of no
association (,5% nominal P values smaller than 0.05 and 0%
smaller than 5610
28). Under a fixed effect size of the causal
SNPs, the most important parameter for power was the r
2
between the causal and tagging SNPs. The product of rac
2 and rbd
2
showed a high correlation with the test statistics of CDH
(Figure 3). As long as rac
26rbd
2.0.1, the CDH test show-
ed a power considerably higher than single SNP association
(Figure 3). In particular, when rac
26rbd
2.0.5 the CDH had 27%
to 91% power to detect a reasonably large effect size (GRR$5) at
the genome-wide significance level (P,5610
28) whereas the
single SNP analysis only had poor power (,10%, Figure 3).
When rac
26rbd
2 approached 1, the collapsed tagging SNPs became
identical to the collapsed causal SNPs and the power of CDH
reached that of the causal SNPs listed in Table 1. Finally, a
higher power was achieved more often when MAFs of S3 and S4
Table 1. Percentage of P values smaller than or equal to the
test threshold for single SNP analysis and collapsed genotype
analysis of two causal variants.
Threshold Threshold Threshold
P # 0.05 P#5e28P #5e211
GRR a b CDH abCDH CDH
1 5.04 4.94 4.97 0.00 0.00 0.00 0.00
2 8.13 8.04 32.98 0.00 0.00 0.46 0.10
3 14.35 15.29 67.74 0.03 0.06 8.04 2.24
4 24.57 24.02 84.58 0.07 0.15 28.34 14.54
5 35.35 34.97 92.57 0.38 0.40 52.51 35.59
6 44.99 46.06 95.80 1.17 1.00 70.58 55.59
7 54.92 55.15 97.41 2.55 2.45 81.53 71.45
8 63.18 64.05 98.57 5.11 4.86 88.62 81.48
9 69.65 70.04 99.02 8.43 8.07 92.56 87.67
10 74.72 74.95 99.36 12.86 13.07 94.81 91.69
a, b, single SNP Cochran-Armitage test of the causal variants a and b.
GRR, genotype relative risk. GRR=1 stands for the null model of no association.
10,000 simulations for each model.
doi:10.1371/journal.pone.0028145.t001
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between r
2 and MAFs.
We further compared power of CDH with WSS through
simulations. In general, the power of WSS increased when the
portion ofcausalvariants included was increased whereasCDHwas
much less influenced by this parameter and outperformed WSS
under all scenarios investigated (Figure 4). The most interesting
scenario is when the portion of causal variants was low (,0.1) and
the causal variants were not directly observed. Under this scenario
the CDH (power 0.41) clearly outperformed WSS (power 0.10).
Software implementation
We implemented the CDH test in the software R package
GenABEL [35,38] and the core computation was implemented
using external C/C++ code. The function was based on a sliding
window approach and performs the CDH test for every SNP over
thegenomewith the followingnSNPs,whichcanbe specified bythe
user. The n SNPs are not necessarily in or outside of known genes.
The minimal P value from each slide is addressed to the first SNP of
this slide and Bonferroni corrected for n tests. The Pearson’s chi-
squared or the Fisher’s exact test is used depending on the number
of individuals in the smallest cell. The total number of tests is N6n-
n(n21)/2, where N is the total number of SNPs on the genome, so
fora givenchip,thecomputationaltime isapproximatelylinearton.
For example, with a dual core processor at 2.5 GHz, screening for
500 K SNPs in 10,000 individuals could be completed in about
7 hours for n=100 and 14 hours for n=200. This implementation
is also practically applicable to imputed data sets and screening for 2
million SNPs could be completed in about 28 hours for n=100 and
56 hours for n=200. The effect of window size is relatively small as
longastheSNPscover,400 kbregion.A window consistingof100
SNPs is on the safe side for screening chips with 500–600 K SNPs.
A GWAS of red hair
We used the red hair color phenotype as the proof of principle
to verify the concept that the use of collapsed genotypes is more
Figure 3. The power of CDH and single SNP analysis. Proportion of P values#5610
28 from the CDH analysis (green dots) and the single SNP
Cochran-Armitage test of two tagging SNPs c (red dots) and d (blue dots). Four SNPs were re-sampled 10,000 times from the Illumina 550 K chip.
SNPs a and b were physically close (,200 kb) and had low MAFs (,5%). SNP c was in LD with a and SNP d was in LD with b. The genotypic relative
risk was simulated according to the genotypes of a and b under the recessive and compound heterozygote model, where GRRAA=GRRBB=GRRAaBb.
The base-line prevalence of a binary phenotype was fixed at 5%. A, when rac
26rbd
2#0.1; B, when 0.1,rac
26rbd
2#0.5; C, when 0.5,rac
26rbd
2#0.9, and
D, when rac
26rbd
2.0.9.
doi:10.1371/journal.pone.0028145.g003
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the same gene locus than traditional GWA analysis. A genome-
wide CDH analysis on red-hair color was conducted in 7732
participants (N red hair=241) of the Rotterdam Study using a
window size of 100 SNPs (Figure S4). At chromosome 16, the
87.88 to 88.69 Mb region containing the MC1R gene, the
association signals from the CDH analyses were uniformly higher
than those from single SNP analyses (Figure 5). The most
significant P value from CDH after the Bonferroni correction of
the window size (P=3.11610
2142 between SNPs rs258322 and
rs8058895) was markedly more significant than seen with the
single SNP association test (P for rs258322=1.33610
266). On
the other hand, there was no inflation of significant results when
the hair color phenotype was randomly shuffled 100 times.
Besides MC1R, no other region showed genome-wide significant
evidence where multiple recessive variants were involved
(Figure S4). To further illustrate the underlying mechanism
that CCDd, CcDD,a n dCCDD carriers did not appear to increase
GRR, which might be counterintuitive, we additionally geno-
typed two important causal SNPs for red hair [24], rs1805007
(R151C) and rs1805008 (R160W), which were not available on
the original chip, in the Rotterdam Study population. Figure 6
shows diplotypes consisting of these two causal SNPs and two
other tagging SNPs for MC1R (Figure 6). The causal alleles A
and B represent rs1805007_T and rs1805008_T, and the tagging
alleles C and D for rs2011877_C and rs2302898_T. These two
tagging SNPs were selected to not be in very high LD with any
causal SNPs for illustration purposes (rab
2=0.007, rac
2=0.147,
rbd
2=0.216). The CCDd genotype is represented by diplotypes 6
and 13, CcDD by 8 and 14, and CCDD only by 15. This example
empirically demonstrated the A–B haplotype at MC1R was
absent in 7732 individuals. It also explained the unique
‘‘antagonistic’’ interaction expressed in the joint penetrance
table of the two tagging SNPs (Table 2) where only the off-
diagonal cells showed any increased prevalence of red hair. The
CDH test of causal SNPs rs1805007 and rs1805008 resulted
in a more significant P value (P=4.9610
2192)t h a nt e s t i n g
them separately (P for rs1805007=3.2610
2139,Pf o r
rs1805008=3.4610
250). The CDH test of only tagging SNPs
rs2011877 and rs2302898 also resulted in a more significant P
value (P=5.9610
232) than testing them separately (P for
rs2011877=6.8610
27, P for rs2302898=8.9610
212), confirm-
ing a power gain when multiple homozygotes and compound
heterozygotes can explain the association. After significant results
are obtained for the CDH test of the tagging SNPs, one can
further test explicitly that CH genotypes in a collapsed set does
have a different effect than the DH genotypes. This test requires
diplotype information, which can be inferred statistically. In this
example, we compared the red and non-red frequencies in
carriers of diplotype 3 against that observed among carriers of
diplotypes 7, 12, and 16 (Figure 6). The P value derived from
this test was also highly significant (P=3.9610
29), pinpointing
that CH, but not DH, could account for the identified
association. Such analysis can be implemented at the genome-
wide scale if the whole genome is phased. Finally, diplotypes 9,
11 and 12 seem to have intermediate prevalence compared to
the recessive homozygotes or CHs. It is known that multiple
causal LOF variants exist in MC1R and the two genotyped are
the most common of these. Thus, the increased prevalence of
diplotypes 9, 11 and 12 can be explained by the CH state of one
of these 2 variants with another non-genotyped causal variant in
MC1R. This also explains that an additive model (Armitage trend
test) does not necessarily perform worse than an explicit recessive
model in single SNP analysis when more than 2 causal recessive
variants exist.
Finally, we compared results of CDH with WSS analysis of
MC1R region (Figure S5). Using the original chip without causal
SNPs rs1805007 and rs1805008, the minimal P value of
1.0610
211 was obtained for WSS when 7 SNPs with
MAF,0.07 were included in the analysis, which is less significant
than the P value from the CDH analysis of all SNP pairs in the
MC1R region (Bonferroni corrected P=7.6610
2142). Assuming
the two causal SNPs rs1805007 and rs1805008 were available on
the chip, the minimal P value (P=2.5610
219) was obtained for
WSS when 14 SNPs with MAF,0.1 were included, which was
also less significant than the P value obtained from the CDH
analysis of all SNPs including the causal ones (Bonferroni
corrected P=1.6610
2190).
Discussion
We demonstrated theoretically and empirically by simulations
that using the collapsed genotypes in GWA analysis is more
powerful than single SNP analysis and the WSS method in
detecting the presence of multiple LOF variants at a particular
gene locus. In a genome scan of the red hair color phenotype this
CDH analysis resulted in considerably more significant association
signals than single SNP analysis at MC1R. Besides MC1R, no other
region of CH association with red hair was identified. By
additional genotyping of two causal SNPs in MC1R we confirmed
Figure 4. The power of CDH and WSS. The power of CDH and
weighted sum statistic (WSS) [29] was plotted against the portion of
causal variants in the sampled region. A region spanning 200 kb was
randomly sampled 10,000 times over the Illumina 550 K chip without
replacement. For each sampling, a binary trait was simulated by
considering a portion of the rare variants in the region to be causal
under the recessive-set model described in [29]. Other parameters were
fixed (a=0.05, n=10,000, and GRR=10 for carriers of any homozygote
or CH genotype of the causal variants). Four sets of P values were
derived when (1) all SNPs in the region were analyzed by CDH (blue), (2)
all SNPs with MAF,0.05 were analyzed by WSS (red), (3) all non-causal
SNPs were analyzed by CDH (green), and (4) all non-causal variants with
MAF,0.05 were analyzed by WSS (purple). The power was defined as
the portion of P values smaller than or equal to 5610
-8.
doi:10.1371/journal.pone.0028145.g004
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The generalizablity of CDH mainly depends on the effect sizes
and frequencies of causal alleles. We expect CDH is generalizable
to some of the known examples, such as HFE and hemochroma-
tosis, where both the allele effect sizes and frequencies are
comparable to MC1R alleles. Further, through simulations we
showed our method is capable to find LOF alleles with smaller
effect sizes (GRR.3) but not with frequencies lower than 1%. It
should therefore be emphasized this approach still requires causal
alleles to be at some appreciable frequency (.1%) to be effectively
tested and probably not useful for exceptionally rare variants.
Herewe focused on a recessiveand CHmodel that addresses, but
not restricted to, the SNP interactions caused by LOF variants. This
type of SNP interaction is only a subtype of CH-like interactions,
e.g. multiple gain function SNPs may well follow the CH model.
However, a number of different models exist in theory, in which
combinations of different variants influence a particular phenotype.
A more ‘omnibus’ hypothesis-testing model may work reasonably
well in multiple or most settings. Still, we believe the proposed CH
model is valuable. First, it has been suggested that LOF variants are
surprisingly common [4,5] and they may account for a substantial
portion of missing heritability [1,3]. Second, the recessive model is
most likely the true model underlying a significant portion of the
causal variants undetected by the GWAS conducted to date. In
conventional single SNP analysis, the required sample size to detect
a recessive allele is a quadratic function of its frequency, which is
much larger than the required sample size to detect a dominant or
additive allele of the same effect size. This is regardless of the
number of causal variants involved at any gene for single SNP
analysis. Thus, we expect an essential portion of the currently
undetected alleles to be recessive. Third, the magnitude of the
power gain of this proposed model is overwhelming for detecting
CH-like interactions, in particular for tagging SNP analysis. The
more significant P value from the CDH test is clearly driven by the
CH carriers. As also shown in the method section, when q1=q2 the
frequency of CH carriers is 4 times higher than homozygote carriers
of single SNP, serving as the driving source of the statistical
significance. Finally, CDHis computationallysimple andpractically
applicable to large-scale data sets.
It has been repeatedly suggested [28,29,39,40] that rare causal
variants are likely to reside on different haplotypes. Under this
scenario, the r
2 between two variants is small and the frequency of
Figure 5. Association between SNPs at MC1R and the red hair color in the Rotterdam Study. The -log10(P) values for association with red
hair color were plotted for each genotyped SNP according to its chromosomal position (blue dots) and for the CDH test in each sliding window
consisting of 100 SNPs (green dots represent the left-most SNP). The LD patterns in the Rotterdam Study population and in the HapMap CEU samples
(release 27) and the known genes in the region were aligned bellow according to the physical position of the SNPs (genome-build version 36.3). The
orange bar indicates the physical position of the MC1R gene. The yellow bar indicates the region between two SNPs based on which the most
significant P value of the CDH test was obtained (the left-most SNP rs258322 and the right-most SNP rs8058895).
doi:10.1371/journal.pone.0028145.g005
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AABB genotype carriers are either unobservable or negligible in
practice and the forming of a collapsed marker by collapsing the
AAbb, aaBB, AaBb genotypes has been described in length
previously [39,40]. What has not been so clear is the scenario
when tagging SNPs with higher minor allele frequencies are in LD
with the rare causal ones, given that the frequency of the CD
haplotype is not close to zero. Through simulations and the
empirical hair color data we showed that the CD haplotype
carriers usually do not have an increased GRR. By grouping
the CcDD, CCDd, and CCDD genotype carriers together with the
wild-type carriers, which is the creative element of this paper, we
have shown that the tagging SNPs are capable of revealing
significant signals. More importantly, iterative analysis of two
tagging SNPs based on a sliding window approach is useful in
genome-wide implementations. The proposed models involve only
two LOF SNPs in weak LD, but of course one could envision
situations in which CH effects could arise due to heterozygosity at a
number of different but physically close loci, such as the MC1R gene
exemplified here or the well-known HLA region. In such cases,
iteratively analyzing two of the variants has an advantage over the
collection-based methods [27,28,29] because power is not compro-
mised by the number of unassociated SNPs included. Although the
downside of this method is the additionalmultiple testing depending
on the window size, which must be sufficiently large to cover all
SNPs potentially inLD,thepowergainisclearlyoverwhelming.For
example, consider the bottom line if the whole genome is tested
pair-wise in the genome-scan of red hair color, the CDH test of
tagging SNPs would still result in a much more significant P value
(10
2142610
12<10
2130) than single SNP analysis (10
266)a tMC1R.
On the other hand, for collection-based methods [27,28,29], power
approaches zero when more and more SNPs are included.
The use of the collapsed genotypes based on tagging or causal
SNPs is conceptually distinguished. The interpretation of results
may be straightforward when the causal variants are directly
available as expected from full genome sequencing data. However,
Figure 6. Frequency of diplotypes and the prevalence of red hair in the Rotterdam Study. The causal SNP a is rs1805007 and b is
rs1805008. The tagging SNP c is rs2011877 and d is rs2302898. Causal alleles A and B are indicated in red color. Common alleles are indicated in green
background and minor alleles are indicated in orange background.
doi:10.1371/journal.pone.0028145.g006
Table 2. Frequency of red hair phenotype as a function of
genotype of two non-causal SNPs tagging the causal variants
at the MC1R gene locus.
rs2011877
GG GT TT
rs2302898 AA 0.00 0.02 0.14
AG 0.02 0.06 0.01
GG 0.22 0.01 0.00
doi:10.1371/journal.pone.0028145.t002
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i.e. based on the currently available genotyping chips, the key
parameter determining the power is the strength of LD in term of r
2
between the underlying causal SNPs and tagging SNPs. In
particular, when rac
26rbd
2.0.5 the CDH provides good to excellent
power to detect a reasonably large effect size in a population based
sample.Acriticalconcernhereistheportionofrarevariantsthatare
well tagged on the existing genome-wide panels. About 20% of low
frequency and physically close SNP pairs from the Illumina 550 k
chip have r
2.0.9 (Figure S1), and about 25% have r
2.0.5. These
estimatesareinlinewitharecentreportshowingpanelsconsistingof
300–550 K SNPs capture only a small proportion of the rare non-
synonymous SNPs (10–27% tagged by r
2.0.5) in Europeans [41].
Thus, the portion of rare SNPs tagged by current chips is far from
desirable for CDHanalysis, except for some candidate traits, such as
exemplified here for red hair. Reference panels such as the
International HapMap Project [42] (http://snp.cshl.org/) and the
1000 Genome Project [43] have already covered up to 7.7 million
newly identified rare variants in multiple human populations. The
recent progress in the imputation techniques has improved the
accuracy of imputing these rare variants [44]. However, in general,
the imputation error rate increases as the minor allele frequency
decreases across all imputation panels and genotyping chips [45].
On the other hand, using CDH to analyze the denser chips can be
safely recommended for screening LOF variants, as in the Illumina
1 M chip, where the density of rare SNPs is already higher than the
common ones [39], although full genome sequencing data would be
ideal. Finally, regional diplotype analysis is recommended after
promising regions are identified with our method. Such promising
regions may be followed up by the case selection approach Wang
and colleagues have proposed for deep-sequencing [40].
The chi-square statistics used here for analyzing binary traits is
simple, and readily extended to general linear models for
analyzing quantitative traits with or without covariates. Rather
than emphasizing the advances in modern statistics, we underline
the known genetic interaction between two or more LOF variants
at the same gene: both homozygotes and the CH genotypes result
in an increased prevalence of phenotype, and taking this into
consideration increases the power in detecting them. The presence
of such variants may be common and should be considered in
routine analysis in genome scans, particularly for extreme
phenotype designs. Our approach is useful in finding these
variants in GWAS carried out with chips of ultra-high density, as
well as future full genome sequencing studies.
Supporting Information
Figure S1 The LD r2 distribution of the physically close
and rare SNP pairs on Illumina 550K chip.
(TIF)
Figure S2 Cross-genotypes between 2 rare SNPs in high
LD.
(TIF)
Figure S3 Expected P values from CDH and single SNP
analyses considering 2 recessive SNPs independently
associated with phenotype. The -log10(P) values for CDH test
(A) and single SNP analysis (B and C) are plotted against the
genotype relative risks of homozygote causal allele (GRR ranging
from 1 to 10). Other parameters are fixed (the frequencies of
causal alleles=0.05, N=10,000, alpha=5%).
(TIF)
Figure S4 Manhattan plot showing association with the
red-hair color phenotype in the Rotterdam Study. The -
log10(P) values for association with red hair color are plotted for each
genotyped SNP according to its chromosomal position (blue dots) and
for the CDH test in each sliding window consisting of 100 SNPs (green
dots).
(TIF)
Figure S5 Association analysis of the MC1R SNPs and
the red hair color using the weighted sum statistic
(WSS). All number of genotyped SNPs in the 87.88 to 88.69 Mb
region of (N SNPs=90) were included to the WSS analysis according
to the minor allele frequencies in the ascending order. The 2log10(P)
values from WSS were plotted against the MAF thresholds (blue dots).
The analysis was then repeated by assuming that two causal SNPs
rs1805007 and rs1805008 were available on the chip (red dots). A, the
2log10(P) values; B, the number of SNPs included in the analysis.
(TIF)
Text S1 Laboratory details for MC1R SNP genotyping.
(DOC)
Table S1 Primers of two MC1R SNPs.
(DOC)
Table S2 An interactive Excel spreadsheet for illustrat-
ing the expected P values from CDH and single SNP
analysis.
(XLS)
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